I don't think it's the webinar, which was held on August 29, just after release of the results. Analyst reports came out on Friday, and some changes were released to the news wires:
30/08/2024 2:12PM Dow Jones MedAdvisor Target Price Raised 27% to A$0.57/Share by Canaccord Genuity
30/08/2024 9:57AM Dow Jones MedAdvisor Price Target Cut 3.1% to A$0.62/Share by Bell Potter
Even though the analyst from Bell Potter slightly reduced the target price, I can see that their EPS forecast for FY26 has actually increased from 0.5 to 1.1 cents.
Maybe someone else came out with a negative report this morning. One or two other brokers also cover MDR.
Add to My Watchlist
What is My Watchlist?